Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume 38, Issue 4, Pages 237-243
Publisher
Springer Nature
Online
2015-01-15
DOI
10.1038/hr.2014.173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR/NDmcr-cp rat model of metabolic syndrome
- (2014) Hironori Nakagami et al. HYPERTENSION RESEARCH
- DPP-4 Inhibition and Neuroprotection: Do Mechanisms Matter?
- (2013) R. P. Shannon DIABETES
- Novel Mechanism for Disrupted Circadian Blood Pressure Rhythm in a Rat Model of Metabolic Syndrome—The Critical Role of Angiotensin II
- (2013) Daisuke Sueta et al. Journal of the American Heart Association
- Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus
- (2012) W. Kothny et al. DIABETES OBESITY & METABOLISM
- Association of seasonal variation in the prevalence of metabolic syndrome with insulin resistance
- (2012) Fumihiko Kamezaki et al. HYPERTENSION RESEARCH
- Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Enhanced Nitric Oxide Release and Reduced Blood Pressure and sICAM-1 Levels in Hypertensive Rats
- (2012) R. Preston Mason et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Roles of central renin-angiotensin system and afferent renal nerve in the control of systemic hemodynamics in rats
- (2011) Yoshihide Fujisawa et al. HYPERTENSION RESEARCH
- Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity
- (2011) Hajime Nagasu et al. HYPERTENSION RESEARCH
- Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes
- (2011) Susumu Ogawa et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Blockade of AT1 Receptors Protects the Blood-Brain Barrier and Improves Cognition in Dahl Salt-Sensitive Hypertensive Rats
- (2010) N. Pelisch et al. AMERICAN JOURNAL OF HYPERTENSION
- Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
- (2010) C. F. Deacon DIABETES OBESITY & METABOLISM
- Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats
- (2010) Bruna PM Pacheco et al. JOURNAL OF HYPERTENSION
- Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats
- (2009) Heung Yong Jin et al. ARCHIVES OF MEDICAL RESEARCH
- Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model
- (2009) Kunio Hirata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Hyperinsulinemic rats are normotensive but sensitized to angiotensin II
- (2008) Maria E. Johansson et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Nocturnal Blood Pressure Dipping in the Hypertension of Autonomic Failure
- (2008) Luis E. Okamoto et al. HYPERTENSION
- Effect of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Blood Pressure in Nondiabetic Patients With Mild to Moderate Hypertension
- (2008) Goutam C. Mistry et al. JOURNAL OF CLINICAL PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started